Instrument Inactif

Autres langues StemGen, Inc. Other OTC

Actions

SGNI

US85858B1098

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

D3eSports Announces REV3AL Partnership for Virtual-to-Real E-Racing Programs	29/11/22
D3eSports Announces Supporting Partnership With United States Esports Federation (USEF)	05/08/22
D3eSports Announces Supporting Partnership With United States Esports Federation	05/08/22
StemGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	04/08/22
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)	04/08/22
D3eSports Announces TCG World For New eSports Series	28/06/22
D3eSports Proudly Announces First Hotel Resort Simulator Destination in Partnership with Newly Launched Team Jamaica	26/05/22
D3eSports Announces Team Jamaica for New eSports Series	20/05/22
D3eSports Announces Innocent Racing Team for D3eSports Cup Championship Series	21/04/22
StemGen Participates in South by Southwest (SXSW) Show	22/03/22
StemGen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	23/02/22
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)	23/02/22
StemGen, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	07/02/22
STEMGEN, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW (form 10-Q)	07/02/22
D3eSports Looks Toward the Metaverse for Greater Engagement with “Virtual-to-Real” Racing Platform	26/01/22
D3eSports Announces Ember Labs as a Corporate Team for the 2022 D3eSports Cup Championship	16/12/21
D3eSports Announces CyberCon as Second Corporate Team for the 2022 D3eSports Cup Championship	07/12/21
D3eSports Announces First Corporate Team for the 2022 D3eSports Cup Championship	18/11/21
STEMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/10/21
Stemgen, Inc. Reports Earnings Results for the Full Year Ended June 30, 2021	15/10/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues StemGen, Inc. Other OTC

Actions

SGNI

US85858B1098

Autres langues

Filtres